Ratings
0
Nobody has rated this yet. Be the first!
Works
5
Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial
Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Amyotrophic lateral sclerosis and soccer: A different epidemiological approach strengthen the previous findings
Amyotrophic lateral sclerosis